← Back
$SPRY All transactions

ARS Pharmaceuticals, Inc.

▼ SELL 10b5-1 Plan

$ Value

$255K

Shares

15,000

Price

$17

Filed

Jul 3

Insider

Name

Karas Eric

Title

Chief Commercial Officer

CIK

0001951287

Roles

Officer

Transaction Details

Transaction Date

2025-07-01

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

10,315

Footnotes

Includes 2,619 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on June 30, 2025. | The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 26, 2024. | The weighted average sale price for the transaction reported was $16.9907, and the range of prices were between $16.71 and $17.31. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. | Immediately exercisable.

Filing Info

Accession No.

0001415889-25-019321

Form Type

4

Issuer CIK

0001671858

Karas Eric's History

Date Ticker Type Value
2026-01-02 SPRY A $0
2025-07-01 SPRY M $22K
2025-07-01 SPRY $255K
2025-07-01 SPRY M $0
2025-06-18 SPRY M $22K
2025-06-18 SPRY $240K
2025-06-18 SPRY M $0

Other Insiders at SPRY (90d)

No other insider activity at this issuer in the last 90 days.